Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on PainChek.
RELATED STOCKHEAD STORIES
Investor Guides
Investor Guide: Health & Biotech FY2025 featuring Tim Boreham
Health & Biotech
ASX Health Stocks: PainChek wins European patent; Phase 3 Trial set to begin for Opthea
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
Allegra’s game-changing Spinal Cage device awaits FDA nod, as ASX medical device stocks make inroads
Health & Biotech
ASX Health Stocks: Painchek’s Europe patent accepted; and HeraMed signs deal with Telstra Health
News
Top 10 at 11: Turned-down takeovers and massive fancy diamonds are where it’s at this morning
News
Rise and Shine: Everything you need to know before the ASX opens
News
ASX Small Caps Lunch Wrap: Who’s had their world turned upside down this week?
Health & Biotech
Check Up: How supramolecular technology is used in biotech, and why L’Oréal wants to get its hands on it
News
Rise and Shine: Everything you need to know before the ASX opens
News
CLOSING BELL: ASX sinks to -1.4pc, despite a late tech rally and some sunny Small Caps news
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
Check Up Budget Edition: Which ASX healthcare stocks will reap benefits from the Budget?
Health & Biotech
Check Up: Japan’s startup OUI wants to halve the world’s blindness with its smartphone device
Health & Biotech
Alzheimer’s drug no longer a moonshot as race heats up, ASX-listed Actinogen in the running
Health & Biotech
ASX Health Stocks: Botanix seeks nod from US FDA; PainChek goes big in Japan
News
